Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/27/2012WO2012129427A2 Aromatic-cationic peptides and uses of same
09/27/2012WO2012129394A2 Methods and compositions for the treatment of cancer
09/27/2012WO2012129385A1 Protection against influenza infection by granulocyte-macrophage colony stimulating factor
09/27/2012WO2012129335A2 Hyd1 peptides for relapsed cancer
09/27/2012WO2012129330A1 Targeted cytokine for treatment of musculoskeletal diseases
09/27/2012WO2012129237A2 Therapeutic agent for emphysema and copd
09/27/2012WO2012129228A2 Novel retro-inverso leptin peptide antagonists
09/27/2012WO2012129186A2 Methods of using peptides derived from the collapsin response mediator protein-2 to provide neuroprotection against injury to the central nervous system
09/27/2012WO2012129165A2 Novel antimicrobial activity of chicken nk-2 peptide against apicomplexan protozoa
09/27/2012WO2012129077A2 Peptides for suppressing inflammation
09/27/2012WO2012128786A2 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
09/27/2012WO2012128709A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof.
09/27/2012WO2012128521A2 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor
09/27/2012WO2012128502A2 Composition for promoting vasculogenesis comprising pauf
09/27/2012WO2012127501A2 Composition for improving endometrial thickness during ovarian stimulation
09/27/2012WO2012127500A2 Composition for spermatogenesis
09/27/2012WO2012127475A1 Neuroprotective peptides
09/27/2012WO2012127441A1 Treatment of proliferative disorders with a chemiluminescent agent
09/27/2012WO2012127392A1 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
09/27/2012WO2012127391A1 Composition comprising diamine oxidase for the prevention of hangover symptoms
09/27/2012WO2012127382A1 Functional foods comprising diamine oxidase and uses thereof
09/27/2012WO2012127381A1 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
09/27/2012WO2012127352A2 Mia (melanoma inhibitory activity) inhibitors for detecting, preventing and curing vitiligo
09/27/2012WO2012127248A1 Method for the production of protein complexes and vaccine compositions comprising the same
09/27/2012WO2012127240A2 Immune assay
09/27/2012WO2012126940A1 Immune suppressor and its use
09/27/2012WO2012126265A1 Recombinant endospore with human serum albumin presented on surface for oral administration and preparation method therefor
09/27/2012WO2012126172A1 Peptides inhibiting adhesion of aspergillus fumigatus to cornea
09/27/2012WO2012126157A1 Annexin v variant, and preparation and use thereof
09/27/2012WO2012126150A1 Peptide with analgesic activity and preparation method thereof
09/27/2012WO2012126047A1 Agent and method for treating pain and reducing inflammation
09/27/2012WO2012106287A3 Methods of treating acute kidney injury with retinoc acid
09/27/2012WO2012104838A8 Use of hgh for the treatment of small for gestational age infants under two years of age
09/27/2012WO2012099973A3 Compositions and methods for treating cancer
09/27/2012WO2012097093A3 Novel wnt compositions and therapeutic uses of such compositions
09/27/2012WO2012075244A3 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
09/27/2012WO2012065181A3 Cancer therapies and diagnostics
09/27/2012WO2003064602A9 Methods of modulating cold sensory perception
09/27/2012US20120246757 Modulation of cellular protein function by artificial sumo ligases
09/27/2012US20120246747 Rna-interference by single-stranded rna molecules
09/27/2012US20120245540 Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
09/27/2012US20120245116 Inhibiting GS-FDH to Modulate No Bioactivity
09/27/2012US20120245106 Modified lysine-mimetic compounds
09/27/2012US20120245105 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
09/27/2012US20120245104 Novel retro-inverso leptin peptide antagonists
09/27/2012US20120245103 Silk Proteins
09/27/2012US20120245102 Partial peptide of lacritin
09/27/2012US20120245101 Synthetic apolipoprotein e mimicking polypeptides and methods of use
09/27/2012US20120245100 Plasmid for expression of transgenes in plants
09/27/2012US20120245099 Apoptosis inducer
09/27/2012US20120245097 Use of pedf-derived polypeptides for promoting stem cells proliferation and wound healing
09/27/2012US20120245096 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
09/27/2012US20120245095 Biglycan and related therapeutics and methods of use
09/27/2012US20120245094 Compounds, compositions and use
09/27/2012US20120245093 Neuronal Viability Factor and Use Thereof
09/27/2012US20120245092 Polypeptides having modulatory effects on cells
09/27/2012US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
09/27/2012US20120245090 Method for screening an agent being useful for the treatment of dry eye and / or corneal and conjunctival lesion and pharmaceutical composition obtained by the method
09/27/2012US20120245089 Use of the sparc microenvironment signature in the treatment of cancer
09/27/2012US20120245088 Compositions comprising igf1 agonists and uses thereof
09/27/2012US20120245087 Novel tissue protective erythropoietin receptor (nepor) and methods of use
09/27/2012US20120245086 WNT10-Derived Peptide and Use Thereof
09/27/2012US20120245085 Pharmaceutical Solution of Non Covalently Bound Albumin and Acylated Insulin
09/27/2012US20120245084 Formulations of diluted amino acid segments and methods for making same
09/27/2012US20120245083 Derivatives of CGRP
09/27/2012US20120245082 Novel Antimicrobial Activity of Chicken NK-2 Peptide Against Apicomplexan Protozoa
09/27/2012US20120245081 Fas peptide mimetics and uses thereof
09/27/2012US20120245080 Mineral salt-sulfonic acid compositions and methods of use
09/27/2012US20120245079 Treatment of Diseases Caused by Bacterial Exotoxins
09/27/2012US20120245078 Means and methods for treating ischemic conditions
09/27/2012US20120245077 Prokineticin 1 receptor
09/27/2012US20120245076 Compositions and methods for delivering rnai using apoe
09/27/2012US20120244236 Composition having lipolysis-promoting effect
09/27/2012US20120244235 Compositions for alleviating inflammation and oxidative stress in a mammal
09/27/2012US20120244232 Black bear parathyroid hormone and methods of using black bear parathyroid hormone
09/27/2012US20120244222 Osmotic mediated release synthetic nanocarriers
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244213 Methods for the treatment of speech impediments
09/27/2012US20120244208 Cosmetic skin care methods and compositions
09/27/2012US20120244196 Pharmaceutical composition containing medicament-containing fine particles and method for producing same
09/27/2012US20120244192 Sustained release formulations of peptidomimetic drugs and uses thereof
09/27/2012US20120244188 Treatment of Sensory Disturbance Disorders
09/27/2012US20120244182 Use of tryptanthrin compounds for immune potentiation
09/27/2012US20120244177 Pharmaceutical composition for treatment of dry eye syndrome
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244172 Conjudates of Pyrrolo[1,4]Benzodiazepine Dimers As Anticancer Agents
09/27/2012US20120244163 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
09/27/2012US20120244157 Use of tnf-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
09/27/2012US20120244156 Leptin as an anti- amyloidogenic biologic and methods for delaying the onset and reducing alzheimer's disease-like pathology
09/27/2012US20120244153 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
09/27/2012US20120244140 Screening method for substance capable of promoting recovery of skin barrier function technical field
09/27/2012US20120244139 Modified proteases that inhibit complement activation
09/27/2012US20120244138 Antidotes for nitrobenzodiazepines
09/27/2012US20120244137 Method of Purifying Pegylated Proteins
09/27/2012US20120244136 Cardiac-Specific Protein Targeting Domain
09/27/2012US20120244134 Process for preparing aqueous dispersions containing high concentration of nano/submicron, hydrophobic, functional compounds
09/27/2012US20120244123 Therapeutic agents
09/27/2012US20120244122 Peptides for the Treatment of HCV Infections
09/27/2012US20120244121 Modulators of toll-like receptor 7
09/27/2012US20120244120 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection
1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 3163